Home passes Biosecure Act, new Chinese language biotech restrictions
WASHINGTON — Congress is poised to move the Biosecure Act after two years of incremental adjustments that watered down the invoice’s curbs on Chinese language biotechs and made the regulation extra palatable for U.S. biopharma firms.
The Home handed a protection funds invoice at this time that features Biosecure, which restricts how U.S. pharmaceutical and biotechnology firms do enterprise with Chinese language firms which are decided to be working with the Chinese language navy and Communist Celebration. It additionally goals to stop these firms from buying People’ delicate genetic knowledge.
The Senate is predicted to vote subsequent week on the Nationwide Protection Authorization Act, together with Biosecure. Congress has handed the NDAA every year for a number of a long time.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
